IP Library Granted Patent US 9,844,508
Granted Patent B2
US 9,844,508 · App. 14/557,393 · Granted Dec 19, 2017

Tumor vaccine and method for producing the same

Inventor: Bo Huang (Wuhan, CN)
Assignee: HUBEI SOUNDNY BIOTECHNOLOGY CO., LTD.
A61K9/009A61K9/0019A61K9/14A61K9/5176A61K39/0011A61K2039/5152
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,844,508
App. No.
14/557,393
Granted
Dec 19, 2017
Kind
B2
Abstract

The invention provides a tumor vaccine and method for producing the same. The tumor vaccine comprises cell vesicles derived from apoptotic tumor cells and an adjuvant. The invention further provides a preparation method of the tumor vaccine, comprising the steps of using the UV to irradiate the tumor cells to induce apoptosis, and collecting the cell vesicles released from the apoptotic tumor cells and then mixing the cell vesicles with the adjuvant to form the tumor vaccine. The tumor vaccine provided by the invention contains a broad and comprehensive tumor antigen spectrum, the defect that the existing tumor vaccine cannot have the killing capacity against the broad tumor cells can be overcome, and at the same time the tumor vaccine has good use safety and immune targeting property.

Claims (7)

1. A tumor vaccine, comprising microparticles, wherein the microparticles are cell vesicles derived from apoptotic tumor cells, and an adjuvant, wherein the microparticles are generated by cellular membrane encapsulating cytosolic contents, and wherein the particle size of the microparticles is 100-1000 nm;

wherein the microparticles are obtained by: centrifuging cell culture medium that contains apoptotic tumor cells and collecting a first supernatant; centrifuging the first supernatant at a centrifugal force of not more than 14000 g so as to remove cells and debris, and collecting a second supernatant; further centrifuging the second supernatant at a centrifugal force of 14,000 g-100,000 g to obtain the microparticles.

2. The tumor vaccine according to claim 1 , wherein the adjuvant is an aluminum adjuvant.

3. The tumor vaccine according to claim 1 , wherein the vaccine is prepared for injection.

4. The tumor vaccine according to claim 1 , wherein the tumor cells comprise ovarian cancer cells, melanoma cells, breast cancer cells, lung cancer cells, gastric cancer cells, colon cancer cells, liver cancer cells, bladder cancer cells, leukemia cells or glioma cells.

5. The tumor vaccine according to claim 1 , wherein the cell vesicles are obtained as follows: using the UV to irradiate the tumor cells to induce apoptosis, and collecting the cell vesicles released from the apoptotic tumor cells.

6. The tumor vaccine according to claim 1 , wherein the vaccine is prepared for injection, and one milliliter of the vaccine contains 4×10 7 -6×10 7 cell vesicles and 0.04-0.06 mg adjuvant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2014
From: HUANG, BO
To: HUBEI SOUNDNY BIOTECHNOLOGY CO., LTD.
Reel/Frame 034292/0713 →
Priority Claims (1)
CN 2012 1 0176820 · May 31, 2012 · national
Continuity (2)
Continuation PCTCN2013076474 · May 30, 2013
Related Publication 20150086639A1 · Mar 26, 2015